Note to the businessman

Found results: 345

Note to the businessman

How to present a biotech project

I can't say that biotech projects are much more difficult to present than IT. With proper elaboration of the presentation at the same time, in 99% of cases it is possible to tell both the concept of the Internet service and the uniqueness of the molecule.

21.11.2012
Note to the businessman

Other people's money

Spending the money of venture investors, people sometimes do not understand their value, while they hesitate to take as much as they need, or take when they are not needed at all.

02.10.2012
Note to the businessman

Investment Search: Investor Tips

The main theses of the master class of Sergey Gribov, Managing Partner of Startup Access and Director of Minerva Capital Partners.

21.09.2012
Note to the businessman

Five million for genome analysis

Station X, a software developer for genomic data analysis and visualization, has raised $5 million from a group of investors led by Runa Capital.

18.09.2012
Note to the businessman

Forbes announces a new startup competition

Startups created no earlier than September 1, 2011, but with an already existing prototype of a technology, product, or the fact of the first sale, if we are talking about services, can take part in the Forbes competition. There are no restrictions on the field of activity.

11.09.2012
Note to the businessman

Medicine + IT = profitable business

If you don't have millions for a new drug, you can try to combine two promising trends and offer additional IT services to the medical market. In Russia, this direction has been actively developing recently.

31.08.2012
Note to the businessman

Startup by the rules

Serial entrepreneur Alexander Dresen has formulated 15 rules that make it possible to go through the difficult path of a startup.

24.08.2012
Note to the businessman

Top 10 pharmaceutical companies in terms of R&D expenses

In 2011, the costs of creating new drugs of the top 10 global pharmaceutical companies in terms of R&D costs amounted to more than $ 70 billion. US$, which is slightly higher than the same indicator in 2010.

28.06.2012
Note to the businessman

Problem area

Residents of the St. Petersburg special economic zone, created 5 years ago, still cannot take advantage of the preferences provided by a residence permit in it.

10.05.2012
Note to the businessman

You can make a good business on genomics

According to the latest report of marketers, by 2016 the market volume of equipment for studying the genome will reach 9 billion US dollars.

18.04.2012
Note to the businessman

Europe develops biotech

The governments of European countries face an important task – to use the results of R&D in the creation of new biotech companies, goods and jobs, emphasized in the report prepared by Ernst & Young and EuropaBio.

29.03.2012
Note to the businessman

Play it down until it gets more expensive!

The Russian stock market has again fallen below 1600 points on the MICEX index, losing almost all the growth observed a week earlier. Meanwhile, domestic pharmaceutical companies traded noticeably better than the market.

26.03.2012
Note to the businessman

Support for startups "at them"

Barack Obama has sent to Congress a package of legislative initiatives that should help accelerate and deepen the development of startups in the United States. And the Rockstart Accelerator startup accelerator has been launched in Europe – do you want to participate?

02.02.2012
Note to the businessman

Startups are expensive now

The average cost of launching an innovative startup in Russia in April-June 2011 was 53 million rubles.

24.01.2012